DURYSTA
NDC 0023-9652, bimatoprost, implant, from Allergan, Inc..
- Product NDC
- 0023-9652
- Status
- Listed
- Labeler
- Allergan, Inc.
- Dosage form
- IMPLANT
- Route
- INTRACAMERAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211911
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0023-9652 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BIMATOPROST10 ug/1
Pharmacologic classes
Prostaglandin Analog [EPC]; Prostaglandins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0023-9652-01 | 00023965201 | 1 IMPLANT in 1 POUCH (0023-9652-01) |
| 0023-9652-03 | 00023965203 | 1 IMPLANT in 1 POUCH (0023-9652-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3f59da84-0bcc-4c84-b3e2-e215681ef341Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0023-9652
Use it
Look up 0023-9652 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0023-9652 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0023-9652. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.